Please enable JavaScript to continue using this application.

Compare $AGEN vs $EBS | Chartloom

Compare

$AGEN vs $EBS

Agenus Inc · Emergent BioSolutions Inc

AGEN

Agenus Inc

EBS

Emergent BioSolutions Inc

Compare $AGEN vs $EBS

Comparing Agenus Inc and Emergent BioSolutions Inc

AGENAgenus Inc

EBSEmergent BioSolutions Inc

AGENAgenus Inc

Market cap

$319M

P/E (TTM)

3.45x

Forward P/E (NTM)

—

Forward P/S (NTM)

3.37x

Rev growth (TTM)

30.5%

YTD performance

137.5%

52W performance

83.9%

FCF yield

-30.8%

EBSEmergent BioSolutions Inc

Market cap

$364M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-9.6%

YTD performance

-43.6%

52W performance

-28.6%

FCF yield

9.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AGEN

EBS

Detailed metrics comparison

AGEN

Agenus Inc

EBS

Emergent BioSolutions Inc

Market Cap

AGEN$319M

EBS$364M

Enterprise Value

AGEN$580M

EBS$806M

Price

AGEN$7.67

EBS$7.06

P/E Ratio

AGEN3.45x

EBSN/A

P/S Ratio

AGEN2.41x

EBS0.47x

EV/Sales

AGEN4.37x

EBS1.05x

EV/EBITDA

AGEN13.66x

EBS3.65x

P/B Ratio

AGEN110.53x

EBS0.95x

P/FCF Ratio

AGENN/A

EBS10.26x

EV/FCF

AGEN-5.89x

EBS22.72x

PEG Ratio

AGENN/A

EBSN/A

Forward P/E (NTM)

AGENN/A

EBSN/A

Forward P/S (NTM)

AGEN3.37x

EBSN/A

Revenue (TTM)

AGEN$133M

EBS$770M

Revenue Growth (YoY)

AGEN30.5%

EBS-9.6%

Forward Rev Growth

AGEN-1.2%

EBS7.1%

Gross Margin (TTM)

AGEN99.5%

EBS55.8%

Operating Margin (TTM)

AGEN103.2%

EBS0.0%

EBITDA Margin (TTM)

AGEN30.6%

EBS28.7%

Net Margin (TTM)

AGEN69.2%

EBS-23.0%

FCF Margin (TTM)

AGEN-74.2%

EBS4.6%

Net Income (TTM)

AGEN$92M

EBS$-177M

FCF (TTM)

AGEN$-99M

EBS$36M

EPS (TTM)

AGEN$2.22

EBS-$3.43

ROE (TTM)

AGEN76.6%

EBS-3591.0%

ROA (TTM)

AGEN44.9%

EBS-1356.0%

ROIC (TTM)

AGEN48.7%

EBS-1622.0%

Cash

AGEN$19M

EBS$140M

Debt

AGEN$280M

EBS$582M

Net Cash/Debt

AGEN$-261M

EBS$-442M

Current Ratio (TTM)

AGEN0.34x

EBS5.42x

Quick Ratio (TTM)

AGEN0.33x

EBS2.74x

Debt/Equity (TTM)

AGEN4.01x

EBS1.70x

Debt/Assets (TTM)

AGEN0.0%

EBS0.0%

Interest Coverage (TTM)

AGENN/A

EBSN/A

Net Debt/EBITDA (TTM)

AGEN0.00x

EBS0.00x

Beta

AGEN1.50

EBS2.42

52W Performance

AGEN83.9%

EBS-28.6%

YTD Performance

AGEN137.5%

EBS-43.6%

% from 52W High

AGEN-25.6%

EBS-49.8%

% from 52W Low

AGEN183.0%

EBS61.9%

Asset Turnover (TTM)

AGEN0.65x

EBS0.59x

FCF Yield (TTM)

AGEN-30.8%

EBS9.7%

Earnings Yield (TTM)

AGEN28.7%

EBS-48.5%

Dividend Yield (TTM)

AGENN/A

EBSN/A

Rule of 40

AGEN-43.8

EBS-4.9

EV/GP/RG

AGENN/A

EBS0.27

Ticker research

View AGEN research View EBS research

Metric	AGEN Agenus Inc	EBS Emergent BioSolutions Inc
Market & Valuation
Market Cap	$319M	$364M
Enterprise Value	$580M	$806M
Price	$7.67	$7.06
P/E Ratio	3.45x	N/A
P/S Ratio	2.41x	0.47x
EV/Sales	4.37x	1.05x
EV/EBITDA	13.66x	3.65x
P/B Ratio	110.53x	0.95x
P/FCF Ratio	N/A	10.26x
EV/FCF	-5.89x	22.72x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.37x	N/A
Revenue & Growth
Revenue (TTM)	$133M	$770M
Revenue Growth (YoY)	30.5%	-9.6%
Forward Rev Growth	-1.2%	7.1%
Profitability
Gross Margin (TTM)	99.5%	55.8%
Operating Margin (TTM)	103.2%	0.0%
EBITDA Margin (TTM)	30.6%	28.7%
Net Margin (TTM)	69.2%	-23.0%
FCF Margin (TTM)	-74.2%	4.6%
Net Income (TTM)	$92M	$-177M
FCF (TTM)	$-99M	$36M
EPS (TTM)	$2.22	-$3.43
ROE (TTM)	76.6%	-3591.0%
ROA (TTM)	44.9%	-1356.0%
ROIC (TTM)	48.7%	-1622.0%
Financial Health
Cash	$19M	$140M
Debt	$280M	$582M
Net Cash/Debt	$-261M	$-442M
Current Ratio (TTM)	0.34x	5.42x
Quick Ratio (TTM)	0.33x	2.74x
Debt/Equity (TTM)	4.01x	1.70x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.50	2.42
52W Performance	83.9%	-28.6%
YTD Performance	137.5%	-43.6%
% from 52W High	-25.6%	-49.8%
% from 52W Low	183.0%	61.9%
Efficiency & Yields
Asset Turnover (TTM)	0.65x	0.59x
FCF Yield (TTM)	-30.8%	9.7%
Earnings Yield (TTM)	28.7%	-48.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-43.8	-4.9
EV/GP/RG	N/A	0.27
Ticker research	View AGEN research	View EBS research

Valuation

P/E Ratio

AGEN

3.45x

P/S Ratio

EBS

0.47x

AGEN

2.41x

EV/FCF

AGEN

-5.89x

EBS

22.72x

Growth & revenue

Revenue Growth TTM

AGEN

30.5%

EBS

-9.6%

Forward Revenue Growth

EBS

7.1%

AGEN

-1.2%

Profitability & performance

Gross Margin

AGEN

99.5%

EBS

55.8%

ROE

AGEN

76.6%

EBS

-3591.0%

FCF Yield %

EBS

9.7%

AGEN

-30.8%

52-Week Performance

AGEN

83.9%

EBS

-28.6%

Detailed metrics comparison

AGEN

Agenus Inc

EBS

Emergent BioSolutions Inc

Market Cap

AGEN$319M

EBS$364M

Enterprise Value

AGEN$580M

EBS$806M

Price

AGEN$7.67

EBS$7.06

P/E Ratio

AGEN3.45x

EBSN/A

P/S Ratio

AGEN2.41x

EBS0.47x

EV/Sales

AGEN4.37x

EBS1.05x

EV/EBITDA

AGEN13.66x

EBS3.65x

P/B Ratio

AGEN110.53x

EBS0.95x

P/FCF Ratio

AGENN/A

EBS10.26x

EV/FCF

AGEN-5.89x

EBS22.72x

PEG Ratio

AGENN/A

EBSN/A

Forward P/E (NTM)

AGENN/A

EBSN/A

Forward P/S (NTM)

AGEN3.37x

EBSN/A

Revenue (TTM)

AGEN$133M

EBS$770M

Revenue Growth (YoY)

AGEN30.5%

EBS-9.6%

Forward Rev Growth

AGEN-1.2%

EBS7.1%

Gross Margin (TTM)

AGEN99.5%

EBS55.8%

Operating Margin (TTM)

AGEN103.2%

EBS0.0%

EBITDA Margin (TTM)

AGEN30.6%

EBS28.7%

Net Margin (TTM)

AGEN69.2%

EBS-23.0%

FCF Margin (TTM)

AGEN-74.2%

EBS4.6%

Net Income (TTM)

AGEN$92M

EBS$-177M

FCF (TTM)

AGEN$-99M

EBS$36M

EPS (TTM)

AGEN$2.22

EBS-$3.43

ROE (TTM)

AGEN76.6%

EBS-3591.0%

ROA (TTM)

AGEN44.9%

EBS-1356.0%

ROIC (TTM)

AGEN48.7%

EBS-1622.0%

Cash

AGEN$19M

EBS$140M

Debt

AGEN$280M

EBS$582M

Net Cash/Debt

AGEN$-261M

EBS$-442M

Current Ratio (TTM)

AGEN0.34x

EBS5.42x

Quick Ratio (TTM)

AGEN0.33x

EBS2.74x

Debt/Equity (TTM)

AGEN4.01x

EBS1.70x

Debt/Assets (TTM)

AGEN0.0%

EBS0.0%

Interest Coverage (TTM)

AGENN/A

EBSN/A

Net Debt/EBITDA (TTM)

AGEN0.00x

EBS0.00x

Beta

AGEN1.50

EBS2.42

52W Performance

AGEN83.9%

EBS-28.6%

YTD Performance

AGEN137.5%

EBS-43.6%

% from 52W High

AGEN-25.6%

EBS-49.8%

% from 52W Low

AGEN183.0%

EBS61.9%

Asset Turnover (TTM)

AGEN0.65x

EBS0.59x

FCF Yield (TTM)

AGEN-30.8%

EBS9.7%

Earnings Yield (TTM)

AGEN28.7%

EBS-48.5%

Dividend Yield (TTM)

AGENN/A

EBSN/A

Rule of 40

AGEN-43.8

EBS-4.9

EV/GP/RG

AGENN/A

EBS0.27

Ticker research

View AGEN research View EBS research

Metric	AGEN Agenus Inc	EBS Emergent BioSolutions Inc
Market & Valuation
Market Cap	$319M	$364M
Enterprise Value	$580M	$806M
Price	$7.67	$7.06
P/E Ratio	3.45x	N/A
P/S Ratio	2.41x	0.47x
EV/Sales	4.37x	1.05x
EV/EBITDA	13.66x	3.65x
P/B Ratio	110.53x	0.95x
P/FCF Ratio	N/A	10.26x
EV/FCF	-5.89x	22.72x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.37x	N/A
Revenue & Growth
Revenue (TTM)	$133M	$770M
Revenue Growth (YoY)	30.5%	-9.6%
Forward Rev Growth	-1.2%	7.1%
Profitability
Gross Margin (TTM)	99.5%	55.8%
Operating Margin (TTM)	103.2%	0.0%
EBITDA Margin (TTM)	30.6%	28.7%
Net Margin (TTM)	69.2%	-23.0%
FCF Margin (TTM)	-74.2%	4.6%
Net Income (TTM)	$92M	$-177M
FCF (TTM)	$-99M	$36M
EPS (TTM)	$2.22	-$3.43
ROE (TTM)	76.6%	-3591.0%
ROA (TTM)	44.9%	-1356.0%
ROIC (TTM)	48.7%	-1622.0%
Financial Health
Cash	$19M	$140M
Debt	$280M	$582M
Net Cash/Debt	$-261M	$-442M
Current Ratio (TTM)	0.34x	5.42x
Quick Ratio (TTM)	0.33x	2.74x
Debt/Equity (TTM)	4.01x	1.70x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.50	2.42
52W Performance	83.9%	-28.6%
YTD Performance	137.5%	-43.6%
% from 52W High	-25.6%	-49.8%
% from 52W Low	183.0%	61.9%
Efficiency & Yields
Asset Turnover (TTM)	0.65x	0.59x
FCF Yield (TTM)	-30.8%	9.7%
Earnings Yield (TTM)	28.7%	-48.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-43.8	-4.9
EV/GP/RG	N/A	0.27
Ticker research	View AGEN research	View EBS research